| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/15/2007 | EP0868176B1 Aminoguanidine for treating niddm |
| 08/15/2007 | CN1332019C Grifola umbellate zymophyte powder and grifola umbellate polysaccharide producing method and products therefrom |
| 08/15/2007 | CN1331865C Polymorphs and compositions and methods related thereto |
| 08/15/2007 | CN1331864C Novel 2,5-diazabicyclo [2.2.1] heptane derivatives |
| 08/15/2007 | CN1331862C Di-aryl acid derivatives as PPAR receptor ligands |
| 08/15/2007 | CN1331860C Protein tyrosine phosphatase 1B inhibitor gamma-butyrolactones compounds and their preparation process and use |
| 08/15/2007 | CN1331857C Fused-polycyclic compounds |
| 08/15/2007 | CN1331856C Polyhydroxy stilbenes compound preparation and uses as drugs for suppressing SARS |
| 08/15/2007 | CN1331855C Antifungal compound and its prepn process and application |
| 08/15/2007 | CN1331853C Small molecule inhibitors of rotamase enzyme activity |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN1331842C Dipyruvate condensed terephthaloyl hydrazone, and its preparing method and use |
| 08/15/2007 | CN1331836C C60 trans-succinate with biologic activity and its synthesis |
| 08/15/2007 | CN1331530C Medicinal preparation for treating stomach and intestine diseases and its preparing method |
| 08/15/2007 | CN1331517C Plaster contg. tuber of hyacinth bletilla |
| 08/15/2007 | CN1331513C Medicine for strengthening child and dispersing food and its preparation method |
| 08/15/2007 | CN1331503C Health-care preparation for reducing blood-fat and raising human-body immunity |
| 08/15/2007 | CN1331487C Chinese patent medicine for hemorrhoid and its preparation |
| 08/15/2007 | CN1331485C Medicine for treating cold |
| 08/15/2007 | CN1331483C Chinese medicine composition for treating snake wound and its use method |
| 08/15/2007 | CN1331478C Vision acuity improving eye drop and its preparation |
| 08/15/2007 | CN1331476C Method for preparing coenzyme-A sublingual lozenge |
| 08/15/2007 | CN1331475C Medication for treating cholecystitis and cholelithiasis, and preparation method |
| 08/15/2007 | CN1331474C Medicinal composition for treating diabetes chronic complication and preparation method of effective component |
| 08/15/2007 | CN1331473C Application of 20(S)-ginsenoside-Rg [3] in the preparing process of medicine for treating or preventing cardiovascular and cerebrovascular disease |
| 08/15/2007 | CN1331472C Quetiapingranulater |
| 08/15/2007 | CN1331471C Combination of valaciclovir hydrochloride soft capsule |
| 08/15/2007 | CN1331470C Method for preparing high stripping-degree hautriwaic glipizide capsule |
| 08/15/2007 | CN1331469C Use of dipolymer of phthalide |
| 08/15/2007 | CN1331468C Plant extractive for treating cancer |
| 08/15/2007 | CN1331467C Ursine fat injection emulsion, and its prepn. method |
| 08/15/2007 | CN1331463C Method for chemo-prevention of prostate cancer |
| 08/15/2007 | CN1331462C Self microemulsion of total dragon's blood flavone |
| 08/15/2007 | CN1331393C Antibacterial composition diffused to resist bacteria in the air and its diffision method |
| 08/15/2007 | CN101019024A Taxol immunoassay method |
| 08/15/2007 | CN101018868A SCHIZOCHYTRIUM fatty acid synthase (FAS) and products and methods related thereto |
| 08/15/2007 | CN101018846A Method for producing unsaturated fatty acid concentrate |
| 08/15/2007 | CN101018799A Composition and method for inhibiting platelet aggregation |
| 08/15/2007 | CN101018793A Phosphorylated polyphenols as colour-stable agents |
| 08/15/2007 | CN101018790A 7-azaindoles and their use as PPAR agonists |
| 08/15/2007 | CN101018787A Ligands for G-protein coupled receptors |
| 08/15/2007 | CN101018785A Thiazolinone 2-substituted quinolines |
| 08/15/2007 | CN101018784A Bicyclic amides as kinase inhibitors |
| 08/15/2007 | CN101018783A Quinoxaline inhibitors of the HEDGEHOG signalling pathway |
| 08/15/2007 | CN101018782A Hydantoin compound for the treatment of inflammatory disorders |
| 08/15/2007 | CN101018781A Bicyclic N-anilide spirolactam CGRP receptor antagonists |
| 08/15/2007 | CN101018780A Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors |
| 08/15/2007 | CN101018779A Triazole compounds and their use as metabotropic glutamate receptor antagonists |
| 08/15/2007 | CN101018778A Substituted oxindol derivatives and medicaments containing the same |
| 08/15/2007 | CN101018777A Process for preparing N-(substituted arylmethyl)-4-substituted-4- (disubstituted methyl) piperidines and intermediates |
| 08/15/2007 | CN101018775A Antiviral agents |
| 08/15/2007 | CN101018773A Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes. |
| 08/15/2007 | CN101018771A Derivatives of pyrazoline, procedure for obtaining them and use thereof as therapeutic agents |
| 08/15/2007 | CN101018770A PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 08/15/2007 | CN101018769A Dimeric piperidine derivates |
| 08/15/2007 | CN101018762A Novel derivatives of 3, 5-seco-4-norcholestane and use thereof |
| 08/15/2007 | CN101018569A Sanitizing composition |
| 08/15/2007 | CN101018567A Induction of apoptosis in Toll-like receptor expressing tumor cells |
| 08/15/2007 | CN101018566A Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 08/15/2007 | CN101018565A Methods for treating conditions associated with MASP-2 dependent complement activation |
| 08/15/2007 | CN101018563A Antimicrobial peptides derived from CAP18 |
| 08/15/2007 | CN101018562A NELL peptide expression systems and bone formation activity of NELL peptide |
| 08/15/2007 | CN101018561A Preparation for use of aspartate and vitamin B12 or biotin for regulating ketone bodies |
| 08/15/2007 | CN101018554A Topical compositions containing phosphorylated polyphenols |
| 08/15/2007 | CN101018553A Methods and related compositions for reduction of fat |
| 08/15/2007 | CN101018552A Intracellular receptor modulator compounds and methods |
| 08/15/2007 | CN101018551A Porphyrin derivatives and their use in photon activation therapy |
| 08/15/2007 | CN101018550A Combination of DPP-IV inhibitors and compounds modulating 5-HT3 and/or 5-HT4 receptors |
| 08/15/2007 | CN101018549A Cla-enriched milkfat and uses thereof |
| 08/15/2007 | CN101018548A Antimicrobial compositions and methods of use thereof |
| 08/15/2007 | CN101018547A 组蛋白脱乙酰基酶抑制剂 Histone deacetylase inhibitors |
| 08/15/2007 | CN101018546A (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 08/15/2007 | CN101018543A Cefdinir oral suspension |
| 08/15/2007 | CN101018542A Testosterone gels comprising propylene glycol as penetration enhancer |
| 08/15/2007 | CN101018537A Wrinkle reduction agent, lipolysis accelerator, composition for external use on skin, and food or beverage composition |
| 08/15/2007 | CN101018519A Adhesive containing wound closure device and method |
| 08/15/2007 | CN101016557A Muskrat fragrant active component prepared by external secretion, preparing process and use |
| 08/15/2007 | CN101016391A Polysaccharides nano material with antibiotic function, preparing method and application thereof |
| 08/15/2007 | CN101016329A Method of preparing cyclopamine from jervine |
| 08/15/2007 | CN101016324A Nucleic acid molecule RTN4BSR62 and application in preparation of anti-cancer drugs |
| 08/15/2007 | CN101016321A Two flavone glycosides in dandelion and medical use for against Gram-positive bacterium thereof |
| 08/15/2007 | CN101016319A Benzoisoselenothiazolidone aminosugar derivative, preparing method and application therheof |
| 08/15/2007 | CN101016313A Method of preparing soybean cephalin, cephalin tablet and active phosphatide granule |
| 08/15/2007 | CN101016312A Method of preparing powder phosphatide and lecithin for medicine and injection from soybean oil residue |
| 08/15/2007 | CN101016301A Triazole miazines derivative |
| 08/15/2007 | CN101016299A Process for preparing purine derivatives |
| 08/15/2007 | CN101016296A Muscarinic agonists |
| 08/15/2007 | CN101016294A Substituted indole-3-oxalamide derivative with multiple bioactivity |
| 08/15/2007 | CN101016286A Extraction method for extraction and pharmaceutical containing the same |
| 08/15/2007 | CN101016283A Preparation of tanhuning |
| 08/15/2007 | CN101016270A Substituted piperazinphenylisoxazoline derivative and use thereof |
| 08/15/2007 | CN101016266A Novel amorphous form of erlotinib hydrochloride and its solid amorphous dispersion |
| 08/15/2007 | CN101016265A Preparation of HIV-1 reverse transcriptase inhibitor and application thereof |
| 08/15/2007 | CN101016264A Nitroimidazole derivative for treatment, preparing method and use |
| 08/15/2007 | CN101016262A N－苯基－2－嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivative |
| 08/15/2007 | CN101016259A Preparing method of high content full cis-beta-carotene preparation |
| 08/15/2007 | CN101016236A Diterpenes compound A in sarcodon scabrosus karst and tumour cell proliferation resistant active |
| 08/15/2007 | CN101015695A Retroviral protease inhibitor combination |
| 08/15/2007 | CN101015694A Compound oral preparation for treating spirobacillus infection of pylorus |
| 08/15/2007 | CN101015678A Nutrient solution for treating patient intestinal dysfunction |